Clio R.
- Country
- Belgium
- Department
- Department of Rheumatology
Research Overview
- Phase I, Single-Blind, Placebo-Controlled Study of ABO21009 in Healthy Volunteers and Rheumatoid Arthritis Patients
- A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Surovatamig in Adults with Rheumatoid Arthritis or Systemic Lupus Erythematosus
- A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Background of Methotrexate (MTX) and Who Have an Inadequate Response to MTX (MTX-IR)
Data & Insights
Has run more than one trial at 173 of 342 partner sites.
Specializations
Inflammatory Arthritis
The investigator specializes in treating various forms of inflammatory arthritis, with particular focus on rheumatoid arthritis and psoriatic arthritis. Their research encompasses evaluating novel therapeutic approaches for patients with moderate to severe disease manifestations.
- Treatment-resistant rheumatoid arthritis
- Biologic therapy optimization
- Early intervention strategies
Their work includes assessment of innovative medications like deucravacitinib, upadacitinib, and rosnilimab for inflammatory joint conditions.
Rheumatic Conditions
The investigator has extensive experience in managing polymyalgia rheumatica, conducting research on long-term treatment approaches and evaluation of novel biological therapies.
- Glucocorticoid-sparing strategies
- Long-term disease management
- Treatment of refractory cases
Their research includes investigation of secukinumab for improving outcomes in polymyalgia rheumatica patients.
Metabolic Disorders
The investigator focuses on treating gout with hyperuricemia, exploring new therapeutic options and comparing their efficacy with established treatments.
- Uric acid management
- Novel therapeutic approaches
- Comparative treatment efficacy
Their research includes evaluation of tigulixostat compared to conventional therapy for patients with gout and hyperuricemia.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.